An approach for the identification of targets specific to bone metastasis using cancer genes interactome and gene

Shikha Vashisht1, Ganesh Bagler

  • 1Biotechnology Division, Institute of Himalayan Bioresource Technology, Council of Scientific and Industrial Research, Palampur, India.

Plos One
|November 21, 2012
PubMed

Insights

This study identifies key genes for secondary bone cancer (SBC) by analyzing a cancer gene network and existing SBC gene data. The findings offer potential therapeutic targets for bone metastasis, a major cancer complication.

Area of Science:

  • Oncology
  • Bioinformatics
  • Systems Biology

Background:

  • Metastasis is a primary driver of cancer mortality, with secondary bone cancer (SBC) frequently complicating breast and prostate cancers.
  • Identifying therapeutic targets for complex, multifactorial diseases like SBC presents a significant challenge due to intricate molecular interactions.

Purpose of the Study:

  • To identify novel therapeutic targets specific to secondary bone cancer (SBC) by integrating network analysis with curated gene datasets.
  • To develop a strategy for probing bone metastasis, a critical aspect of cancer progression and mortality.

Main Methods:

  • Construction of a 'Cancer Genes Network' representing a protein interactome of cancer genes.
  • Application of graph theoretical methods to identify key genes involved in generic cancer mechanisms and biological essentiality.
  • Compilation of a curated dataset of 391 SBC genes and integration with gene ontology enrichment for target identification.

Main Results:

  • Identification of a set of key genes relevant to generic cancer mechanisms and biological essentiality through network analysis.
  • Development of a strategy combining generic cancer genes, SBC genes, and gene ontology enrichment to pinpoint bone metastasis-specific targets.
  • Presentation of potential therapeutic targets with ontological and regulatory relevance to SBC.

Conclusions:

  • The study provides a novel approach for investigating cancer metastasis, specifically secondary bone cancer.
  • Network analysis of the 'Cancer Genes Network' yields insights into molecular regulators of cancer phenotypes.
  • The identified gene targets offer a foundation for developing more effective treatments for bone metastasis.